-transparent.png){kind=logo}
The treatment of psoriasis and psoriatic arthritis by cyclosporin A, a new immunosuppressive agent believed to have a largely selective action on T lymphocytes, is described. Results in 4 cases show that cyclosporin A can bring about a most impressive improvement in psoriatic lesions of the skin and its appendages, but that its effect on the arthropathy is variable. There is still little certainty about the compound's mechanism of action in these conditions. Cyclosporin A may give rise to a whole range of side effects and its use--like that of other immunosuppressants--should therefore be contemplated only in severe and progressive forms of psoriasis and psoriatic arthritis resistant to other forms of treatment except cytostatic drugs.
W Müller, and
U Graf
January 1984,
Duodecim; laaketieteellinen aikakauskirja,
W Müller, and
U Graf
July 1983,
ZFA. Zeitschrift fur Allgemeinmedizin,
W Müller, and
U Graf
October 1983,
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
W Müller, and
U Graf
September 1981,
Colorado medicine,
W Müller, and
U Graf
April 1984,
Casopis lekaru ceskych,
W Müller, and
U Graf
November 1981,
Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
W Müller, and
U Graf
October 1982,
Mutation research,
W Müller, and
U Graf
January 1985,
Medicina,
W Müller, and
U Graf
March 1979,
Transplantation proceedings,
W Müller, and
U Graf
September 1983,
Ugeskrift for laeger,
